| 陈琳,彭永德.骨质疏松症的药物治疗新进展[J].中国临床保健杂志,2025,28(5):628-630. |
| 骨质疏松症的药物治疗新进展 |
| New progress in drug therapy for osteoporosis |
| 投稿时间：2025-05-10 |
| DOI：10.3969/J.issn.1672-6790.2025.05.008 |
| 中文关键词: 骨质疏松 药物疗法 精准医学 综述 |
| 英文关键词: Osteoporosis Drug therapy Precision medicine Review 〖FL |
| 基金项目:国家重点研发计划项目(23Z010701386) |
|
| 摘要点击次数: 44 |
| 全文下载次数: 26 |
| 中文摘要: |
| 骨质疏松症是一种以骨量减少和骨微结构破坏为特征的全身性骨骼疾病,严重影响患者生活质量。骨质疏松症的药物治疗主要包括基础用药、抗骨吸收药物和促骨形成药物,联合用药和序贯用药策略逐渐受到关注。未来,药物治疗将朝着精准化和个体化的方向发展。本文综述了骨质疏松症药物治疗的最新进展,探讨骨质疏松症药物治疗面临的挑战和未来发展方向,为临床实践和药物研发提供参考。 |
| 英文摘要: |
| Osteoporosis is a systemic skeletal disease characterized by reduced bone mass and compromised bone microarchitecture,which significantly impairs patients′ quality of life.Currently,drug treatments of osteoporosis predominantly include foundational therapies,anti-bone resorption agents,and bone formation promoters.Combination and sequential treatment strategies have garnered increasing attention.In the future,drug therapies are expected to progress towards precision and personalization.This article provides a comprehensive review of the latest advancements in drug therapy for osteoporosis,explores the challenges and potential directions for the future development of osteoporosis drug therapy,offering valuable insights for clinical practice and pharmaceutical research. |
|
查看全文
|
| 关闭 |
|
|
|